Neuralink
About Neuralink
Neuralink is a neurotechnology company focused on developing brain-computer interfaces to restore autonomy for people with unmet medical needs and to advance human potential. The organization conducts research and development in neural interfaces, aiming to treat neurological conditions and enable new forms of human-machine interaction. Its work is positioned as global in scope, with emphasis on medical applications for paralysis and related impairments. The company communicates a long-term mission of redefining human capabilities through advanced neural implants.
Recent News
No Keynotes, No BS — Why This Year’s Best Tech Talks Happened over Cocktails at StrictlyVC
Neurable Licenses $700 Consumer BCI Headphones, Secures $1.2M Pentagon Deal
On the Stand, Elon Musk Can’t Escape His Own Tweets
Did Neuralink Make the Wrong Bet?
CorTec Becomes First German BCI Company to Get FDA Breakthrough Designation
University of Colorado Boulder Finds Brain Circuit That May Flip Acute Pain Into Chronic Pain
The Future Will Be Explained to You in Palo Alto
ARK Venture Fund Lets Retail Investors Buy Into SpaceX, OpenAI and Anthropic
SpaceX to Acquire AI Coding Startup Cursor in $60 B Deal
OpenAI Invests in Sam Altman’s Brain Computer Interface Startup Merge Labs
SpaceX Bought Nearly 20% Of Tesla Cybertrucks Sold In Q4
Neuralink Shifts to Speech‑Focused Brain‑Computer Interface Trials, Raising Viability Questions
Edward ‘Big Balls’ Coristine Is Helping Out on Viral Fraud Videos Now
Registration Opens for Robotics Summit & Expo 2026
Beyond the Chatbot: Why the Future of AI Needs to See What You See
CorTec Secures FDA Breakthrough Designation for Stroke‑Rehab Brain‑Computer Interface
FDA Approves First‑In‑Human Trial of Motif Neurotech’s Depression Brain Implant
Bidirectionality Is the Obvious BCI Paradigm
Scientists May Have Found the Brain’s Switch for Chronic Pain
The New Gold Rush in Brain Science
China’s Brain-Computer Interface Industry Is Racing Ahead
Technological Telepathy: Is an ”Internet of Minds” Possible?
Bye-Bye Corporate Conglomerates. Hello Personal Conglomerates.
Will 2026 See a ‘ChatGPT Moment’ for Microchip Implants?
This Mind-Reading Beanie Could Make Keyboards Obsolete
‘Warcraft… with Pure Thought Control’ — 100 Days with Neuralink ‘Feels Like Science Fiction’ to Early Brain Chip Pioneer
Weekly Reads: Organoids ‘Pregnant’ with Human Embryos, Neuralink, Biotech Scorecard, Iffy Autism Tests
SpaceX S-1 Reveals Tesla’s Terafab Deal Is Far From Done
This Beanie Is Designed to Read Your Thoughts
The ‘AI Is Inevitable’ Trap
How Many Cybertrucks Has Tesla Sold to the Public? Fewer than You Might Think
CorTec’s Brain Interchange BCI Gains FDA TAP Enrollment, Accelerating Stroke Rehab Path
Gabe Newell Was an Enthusiastic Supporter of OpenAI in 2018, Donating $20 Million and Even Acting as the Sole Member of an 'Informal Advisory Board'
Epia Neuro Unveils Brain Implant to Restore Hand Function in Stroke Survivors
Is The Next Wave of Wellness a Fitbit for Your Brain?
Musk Expects Widespread Use of Cars Without Human Monitors in U.S. This Year
"Taiwan Loses Its Strategic Importance In 18 Months," Says Chamath Palihapitiya
Shivon Zilis, Mother of Four of Elon Musk’s Children, Testifies in OpenAI Trial
Energy, Healthcare and Utilities: How to Tap Into AI in the Real Economy
How Elon Musk’s SpaceX Could Supercharge the Next IPO Frenzy
DOGE Affiliate Is Now in Charge of the US Government’s ID Platform
A New Implant Aims to Rewire the Brain to Help Stroke Patients
Sequoia Partner Spreads Debunked Brown Shooting Theory, Testing New Leadership
San Francisco–Based Venture University Launches UK Investor Accelerator
What We Learned From the Cringey Courtroom Drama Between Elon Musk and Sam Altman
BCI Startup Neurable Looks to License Its ‘Mind-Reading’ Tech for Consumer Wearables
Musk’s Day‑4 Testimony Highlights AI Rivalry and $38 M Donation Dispute
Max Hodak’s Science Corp. Is Preparing to Place Its First Sensor in a Human Brain
China Is Moving Faster on Next-Gen Tech. The U.S. Is Trying to Keep Up
Recent Deals
No recent deals for this company.